Warpaint London PLC Blocklisting Application (1705Y)

TIDMW7L

RNS Number : 1705Y

Warpaint London PLC

02 May 2023

2 May 2023

Warpaint London PLC

("Warpaint", the "Company" or the "Group")

Blocklisting Application

Warpaint London plc (AIM: W7L), the specialist supplier of colour cosmetics and owner of the W7 and Technic brands, announces that it has today made an application to AIM for the block listing of 385,633 ordinary shares of 25p each ("Ordinary Shares"). These Ordinary Shares will be available to satisfy the future exercises of options granted on 20 May 2020 over Ordinary Shares under the Warpaint London plc Company Share Option Plan ("CSOP").

These shares, when issued, will rank pari passu in all respects with the existing Ordinary Shares and it is expected that admission will occur on Tuesday 9 May 2023.

Enquiries:

 
 Warpaint London                                      c/o IFC 
  Sam Bazini - Chief Executive Officer 
  Eoin Macleod - Managing Director 
  Neil Rodol - Chief Financial Officer 
 Shore Capital (Nominated Adviser and Broker) 
  Patrick Castle, Daniel Bush - Corporate Advisory 
  Fiona Conroy - Corporate Broking                    020 7408 4090 
 IFC Advisory (Financial PR & IR) 
  Tim Metcalfe, Graham Herring, Florence Chandler     020 3934 6630 
 

Warpaint London plc

Warpaint sells branded cosmetics under the lead brand names of W7 and Technic. W7 is sold in the UK primarily to retailers and internationally to local distributors or retail chains. The Technic brand is sold in the UK and continental Europe with a significant focus on the gifting market, principally for high street retailers and supermarkets. In addition, Warpaint supplies own brand white label cosmetics produced for several major high street retailers. The Group also sells cosmetics using its other brand names of Man'stuff, Body Collection and Chit Chat.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ALSFLFVEEIIFIIV

(END) Dow Jones Newswires

May 02, 2023 11:31 ET (15:31 GMT)